![Figure][1] I am honored for the opportunity to lead the journal and build upon the strong success of the past decade under the founding Editor-in-Chief, Dr. Dan Von Hoff, his Deputy and Senior Editors, and the Editorial Board. Since its launch in late 2001, Molecular Cancer Therapeutics (
No takes yet. Share an insight, caveat, or question.
John C. Reed (2012) studied this question.